Literature DB >> 19763935

eQTL analysis in humans.

Lude Franke1, Ritsert C Jansen.   

Abstract

Improving human health is a major aim of medical research, but it requires that variation between individuals be taken into account since each person carries a different combination of gene variants and is exposed to different environmental conditions, which can cause differences in susceptibility to diseases. With the advent of molecular markers in the 1980s, it became possible to genotype individuals (i.e., to detect the presence or absence of local DNA sequence variants at each of hundreds of genome positions). This DNA sequence variation could then be related to disease susceptibility by using pedigree data. Such linkage analyses proved to be difficult for more complex diseases. Recently, with the decreasing costs of genotyping, analyses of large natural populations of unrelated individuals became possible and resulted in the association of many genes (and genetic variants in these genes) with complex diseases. Unfortunately, for a considerable proportion of these genes and their proteins, it is not yet clear what their downstream effects are. Studying the expression of these genes and proteins can help to uncover the effects of these variants on the expression of these and other genes, proteins, metabolites, and phenotypes. In this chapter, we focus on the high-throughput and genome-wide measurement of gene expression in a natural population of unrelated humans, and on the subsequent association of variation in expression to "expression quantitative trait loci" (eQTLs) on DNA using oligonucleotide arrays with hundreds of thousands of single-nucleotide polymorphism (SNP) markers that capture most of the human genetic variation well. This strategy has been successfully applied to several diseases such as celiac disease (Hunt et al. 2008, Nat Genet 40, 395-402) and asthma (Moffatt et al. 2007, Nature 448, 470-473): associated genetic variants have been identified that affect levels of gene expression in cis or in trans, providing insight into the biological pathways affected by these diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19763935     DOI: 10.1007/978-1-60761-247-6_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

Review 1.  Computational tools for discovery and interpretation of expression quantitative trait loci.

Authors:  Fred A Wright; Andrey A Shabalin; Ivan Rusyn
Journal:  Pharmacogenomics       Date:  2012-02       Impact factor: 2.533

2.  Cd14 SNPs regulate the innate immune response.

Authors:  Hong-Hsing Liu; Yajing Hu; Ming Zheng; Megan M Suhoski; Edgar G Engleman; David L Dill; Matt Hudnall; Jianmei Wang; Rosanne Spolski; Warren J Leonard; Gary Peltz
Journal:  Mol Immunol       Date:  2012-03-23       Impact factor: 4.407

3.  Pilot study demonstrating potential association between breast cancer image-based risk phenotypes and genomic biomarkers.

Authors:  Hui Li; Maryellen L Giger; Chang Sun; Umnouy Ponsukcharoen; Dezheng Huo; Li Lan; Olufunmilayo I Olopade; Andrew R Jamieson; Jeremy Bancroft Brown; Anna Di Rienzo
Journal:  Med Phys       Date:  2014-03       Impact factor: 4.071

4.  Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses.

Authors:  Oliver Stegle; Leopold Parts; Matias Piipari; John Winn; Richard Durbin
Journal:  Nat Protoc       Date:  2012-02-16       Impact factor: 13.491

5.  Correlation analyses revealed global microRNA-mRNA expression associations in human peripheral blood mononuclear cells.

Authors:  Lan Wang; Jiang Zhu; Fei-Yan Deng; Long-Fei Wu; Xing-Bo Mo; Xiao-Wei Zhu; Wei Xia; Fang-Fei Xie; Pei He; Peng-Fei Bing; Ying-Hua Qiu; Xiang Lin; Xin Lu; Lei Zhang; Neng-Jun Yi; Yong-Hong Zhang; Shu-Feng Lei
Journal:  Mol Genet Genomics       Date:  2017-09-06       Impact factor: 3.291

6.  Expression analysis of loci associated with type 2 diabetes in human tissues.

Authors:  C Cotsapas; L Prokunina-Olsson; C Welch; R Saxena; C Weaver; N Usher; C Guiducci; S Bonakdar; N Turner; B LaCroix; J L Hall
Journal:  Diabetologia       Date:  2010-08-12       Impact factor: 10.122

7.  Multiple common variants for celiac disease influencing immune gene expression.

Authors:  Patrick C A Dubois; Gosia Trynka; Lude Franke; Karen A Hunt; Jihane Romanos; Alessandra Curtotti; Alexandra Zhernakova; Graham A R Heap; Róza Adány; Arpo Aromaa; Maria Teresa Bardella; Leonard H van den Berg; Nicholas A Bockett; Emilio G de la Concha; Bárbara Dema; Rudolf S N Fehrmann; Miguel Fernández-Arquero; Szilvia Fiatal; Elvira Grandone; Peter M Green; Harry J M Groen; Rhian Gwilliam; Roderick H J Houwen; Sarah E Hunt; Katri Kaukinen; Dermot Kelleher; Ilma Korponay-Szabo; Kalle Kurppa; Padraic MacMathuna; Markku Mäki; Maria Cristina Mazzilli; Owen T McCann; M Luisa Mearin; Charles A Mein; Muddassar M Mirza; Vanisha Mistry; Barbara Mora; Katherine I Morley; Chris J Mulder; Joseph A Murray; Concepción Núñez; Elvira Oosterom; Roel A Ophoff; Isabel Polanco; Leena Peltonen; Mathieu Platteel; Anna Rybak; Veikko Salomaa; Joachim J Schweizer; Maria Pia Sperandeo; Greetje J Tack; Graham Turner; Jan H Veldink; Wieke H M Verbeek; Rinse K Weersma; Victorien M Wolters; Elena Urcelay; Bozena Cukrowska; Luigi Greco; Susan L Neuhausen; Ross McManus; Donatella Barisani; Panos Deloukas; Jeffrey C Barrett; Paivi Saavalainen; Cisca Wijmenga; David A van Heel
Journal:  Nat Genet       Date:  2010-02-28       Impact factor: 38.330

8.  FastEpistasis: a high performance computing solution for quantitative trait epistasis.

Authors:  Thierry Schüpbach; Ioannis Xenarios; Sven Bergmann; Karen Kapur
Journal:  Bioinformatics       Date:  2010-04-07       Impact factor: 6.937

Review 9.  Integrative systems biology approaches in asthma pharmacogenomics.

Authors:  Amber Dahlin; Kelan G Tantisira
Journal:  Pharmacogenomics       Date:  2012-09       Impact factor: 2.533

Review 10.  Translational genetics for diagnosis of human disorders of sex development.

Authors:  Ruth M Baxter; Eric Vilain
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-15       Impact factor: 8.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.